Skip to main content
. 2023 Jul;68(7):939–960. doi: 10.4187/respcare.10825

Fig. 8.

Fig. 8.

Primary and secondary outcomes of the LIBERATE randomized controlled trial with use of the Zephyr endobronchial valve to treat heterogenous emphysema. From Reference 35, with permission. 6MWD = 6 minute walk distance; SRGQ = St George’s Respiratory Questionnaire; EBV = endobronchial valve.